首页> 外文会议>Meeting of the Electrochemical Society;International Meeting on Chemical Sensors >Nano-Level DL-Methionine Biosensing in Blood Serum and Urine Using CuO/AgO Modified Graphite Electrode
【24h】

Nano-Level DL-Methionine Biosensing in Blood Serum and Urine Using CuO/AgO Modified Graphite Electrode

机译:纳米级DL-甲硫氨酸在血清和尿液中使用CUO / age改性石墨电极

获取原文

摘要

DL-methionine (DLM) is a common precursor for some amino acids essential to human physiology, (e.g. homocysteine and cysteine). Its contribution to detoxification and regulation of cell aging as well as fat build-up makes it an essential ingredient in the body fluids. Changes in blood level DL-methionine concentration may not be detrimental to human health, however, its contribution to regulating homocysteine level may contribute to some metabolic disorder in diabetic patients with non-cardiovascular diseases. The current research report features a new approach developed towards fabricating a new CuO/AgO modified graphite pencil electrode for sensing in human blood serum and urine samples at the nanoscale limit of detection. The fabricated sensor was characterized by means of X-ray Photoelectron Spectroscopy, Raman spectroscopy and scanning electron microscopy while being used to detect the DLM analyte. Electrode reactions were monitored using cyclic voltammetric and electrochemical impedance spectroscopic methods. The Ag-induced catalytic activity between pH 7-10 was observed following oxidation of the analyte at the electrode surface in the presence of hydroxide ions. DLM detection was ascribed to the unique electroactive Ag and Cu sites on the sensor electrode. The efficiency of this sensor towards analyte sensing within these biological samples in the presence of potential interferences was also investigated. This study features the success in DLM sensing in the presence of multiple amino acid interferences in complex biological samples. With the emergence of complications involving some neuro and cerebrovascular diseases associated with residual methionine, this work presents a biomolecular means of sensing of DLM as a disease biomarker at the nanoscale. The lowest DLM detection limit (DL) in this study was in the nanomolar level; 50 and 60 nM DLM in the serum and urine, respectively.
机译:DL-METIONINE(DLM)是对人生理学必需必然的一些氨基酸的常见前体,(例如同型半胱氨酸和半胱氨酸)。它对细胞衰老的排毒和调节以及脂肪堆积的贡献使其成为体液中必不可少的成分。血液水平Dl-甲硫氨酸浓度的变化可能对人体健康不利,但是其对调节同型同型内膜水平的贡献可能导致糖尿病患者的一些代谢障碍的非心血管疾病。目前的研究报告采用了一种新的方法,用于制造新的CUO / aGu修改的石墨铅笔电极,用于在纳米级检测极限下感测人血清和尿液样本。制造的传感器的特征在于X射线光电子能谱,拉曼光谱和扫描电子显微镜,同时用于检测DLM分析物。使用循环伏安和电化学阻抗光谱法监测电极反应。在氢氧化物离子存在下在电极表面的分析物氧化后观察到pH 7-10之间的Ag诱导的催化活性。 DLM检测归因于传感器电极上的独特电活性Ag和Cu位点。还研究了该传感器在这些生物样品中存在潜在干扰存在的分析物感测的效率。该研究在复杂生物样品中存在多种氨基酸干扰的情况下DLM感测的成功。随着涉及与残留甲硫氨酸相关的一些神经和脑血管疾病的并发症的出现,该工作呈现了DLM作为纳米级疾病生物标志物的生物分子感测的生物分子。本研究中最低的DLM检测限(DL)处于纳米摩尔水平;分别在血清和尿液中50和60nm DLM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号